Literature DB >> 21692829

Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.

Belén Valenzuela, Joseba Rebollo, Tania Pérez, Antonio Brugarolas, Juan José Pérez-Ruixo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21692829      PMCID： PMC3244646          DOI： 10.1111/j.1365-2125.2011.04052.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  21 in total

1.  Ways to fit a PK model with some data below the quantification limit.

Authors:  S L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

2.  The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.

Authors:  J Hirth; P B Watkins; M Strawderman; A Schott; R Bruno; L H Baker
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  A population pharmacokinetic model for docetaxel (Taxotere): model building and validation.

Authors:  R Bruno; N Vivier; J C Vergniol; S L De Phillips; G Montay; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

4.  Therapeutic drug monitoring for the individualization of docetaxel dosing: a randomized pharmacokinetic study.

Authors:  Frederike K Engels; Walter J Loos; Jessica M van der Bol; Peter de Bruijn; Ron H J Mathijssen; Jaap Verweij; Ron A A Mathot
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

5.  Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.

Authors:  M M Malingré; D J Richel; J H Beijnen; H Rosing; F J Koopman; W W Ten Bokkel Huinink; M E Schot; J H Schellens
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

6.  Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Authors:  R Bruno; D Hille; A Riva; N Vivier; W W ten Bokkel Huinnink; A T van Oosterom; S B Kaye; J Verweij; F V Fossella; V Valero; J R Rigas; A D Seidman; B Chevallier; P Fumoleau; H A Burris; P M Ravdin; L B Sheiner
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

7.  Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.

Authors:  Frederike K Engels; Albert J Ten Tije; Sharyn D Baker; Carlton K K Lee; Walter J Loos; Arnold G Vulto; Jaap Verweij; Alex Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2004-05       Impact factor: 6.875

8.  Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.

Authors:  Maria L Veronese; Lisa P Gillen; Joanne P Burke; Ellen P Dorval; Walter W Hauck; Ed Pequignot; Scott A Waldman; Howard E Greenberg
Journal:  J Clin Pharmacol       Date:  2003-08       Impact factor: 3.126

9.  Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

Authors:  Sharyn D Baker; Ming Zhao; Carlton K K Lee; Jaap Verweij; Yelena Zabelina; Julie R Brahmer; Antonio C Wolff; Alex Sparreboom; Michael A Carducci
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

Review 10.  Pharmacokinetics and metabolism of Taxotere (docetaxel).

Authors:  R Bruno; G J Sanderink
Journal:  Cancer Surv       Date:  1993
View more
  7 in total

1.  Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

Review 2.  Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.

Authors:  Flavia Storelli; Caroline Samer; Jean-Luc Reny; Jules Desmeules; Youssef Daali
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

3.  A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs.

Authors:  Amer A Koni; Maisa A Nazzal; Bushra A Suwan; Samah S Sobuh; Najiya T Abuhazeem; Asil N Salman; Husam T Salameh; Riad Amer; Sa'ed H Zyoud
Journal:  BMC Cancer       Date:  2022-05-14       Impact factor: 4.638

Review 4.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

5.  Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.

Authors:  Marion Paolini; Laurence Poul; Céline Berjaud; Matthieu Germain; Audrey Darmon; Maxime Bergère; Agnès Pottier; Laurent Levy; Eric Vibert
Journal:  Int J Nanomedicine       Date:  2017-08-02

Review 6.  Food and Drug Interactions.

Authors:  Jong Hwan Choi; Chang Mann Ko
Journal:  J Lifestyle Med       Date:  2017-01-31

Review 7.  Herbal Interaction With Chemotherapeutic Drugs-A Focus on Clinically Significant Findings.

Authors:  Pius S Fasinu; Gloria K Rapp
Journal:  Front Oncol       Date:  2019-12-03       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.